Voss Capital, LLC bought $423k of RNTX
owner at Aileron Therapeutics, Inc.. 306,050 shares at an average of $1.38, traded Oct 24, 2025, filed Oct 28, 2025.
Score components
- +12Role10% owner
- +16Trade size$423k at market
- +6Relative to holdingsHoldings up 44%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +16.7%, 3m +17.4%, 6m +9.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000921895-25-002819, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 24, 2025 | POpen-market purchase Common Stock, $0.001 par valueindirect: By: Voss Value Master Fund, L.P. | +30,176 | $1.39 | $42k | 729,616 | Oct 28, 2025 |
| Oct 27, 2025 | POpen-market purchase Common Stock, $0.001 par valueindirect: By: Voss Value Master Fund, L.P. | +92,642 | $1.37 | $127k | 822,258 | Oct 28, 2025 |
| Oct 27, 2025 | POpen-market purchase Common Stock, $0.001 par valueindirect: By: Voss Value-Oriented Special Situations Fund, L.P. | +4,840 | $1.37 | $6,625 | 321,608 | Oct 28, 2025 |
| Oct 28, 2025 | POpen-market purchase Common Stock, $0.001 par valueindirect: By: Voss Value-Oriented Special Situations Fund, L.P. | +178,392 | $1.39 | $248k | 500,000 | Oct 28, 2025 |
Related signals
Other insiders at Aileron Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | RNTXbuy Aileron Therapeutics, Inc. | Josef H Von Rickenbach director | $50k 47,060 shares | +305% | |
| 38Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor See Remarks | $25k 25,000 shares | +1222% | |
| 26Weak | RNTXbuy Aileron Therapeutics, Inc. | Voss Capital, LLC owner | $128k 104,183 shares | +13% | |
| 33Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor President and CEO | $898 400 shares | - | |
| 12Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $22k 6,607 shares | -0% | |
| 21Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $81k 24,671 shares | -1% | |
| 18Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $41k 12,315 shares | -1% | |
| 21Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $85k 20,315 shares | -1% | |
| 23Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $139k 31,151 shares | -2% | |
| 37Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor President and COO | $758 225 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.